{
    "nct_id": "NCT06609343",
    "official_title": "Bupropion for Fatigue in End-stage Kidney Disease Patients on Hemodialysis (BRISK)",
    "inclusion_criteria": "1. Male and female ESKD patients between aged 25-74 yrs on maintenance in-center hemodialysis procedure 3 times/week for ≥3 months with an arteriovenous fistula or graft.\n2. Blood hemoglobin of ≥10.0 g/dL based on most recent routine laboratory profile.\n3. Dialysis adequacy measured with Kt/V of ≥1.2\n4. Ability to understand and the willingness to sign a written informed consent document\nHealthy volunteers allowed\nMust have minimum age of 25 Years\nMust have maximum age of 74 Years",
    "exclusion_criteria": "1. Currently on bupropion or hypersensitivity/ intolerance to bupropion by history and monoamine oxidase inhibitors.\n2. Diagnosis or history of eating disorders (bulimia or anorexia nervosa) and seizure.\n3. Pregnant, lactating, childbearing women\n4. History of post-acute COVID-19 syndrome\n5. Diagnosis of depression and/or on antidepressants and bipolar affective disorder\n6. Patient Health Questionnaire (PHQ)-9 score of ≥10\n7. Diagnosis of cognitive impairment including dementia\n8. Current participation in another interventional trial\n9. Scheduled for kidney transplantation in next 6 months\n10. Life expectancy <6 months as judged by the attending nephrologist/primary care physician.\n11. Current or history of substance abuse or dependency.",
    "miscellaneous_criteria": ""
}